Just a few puffs into each nostril, and you're protected against infection from nasty cold viruses - that is, according to claims made for many nasal sprays. Can they really do this?Well, not directly ...

Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

Babies under 8 months old are eligible to get an RSV vaccine, and women who are pregnant can also get it to protect kids before they're born. The vaccine is available now through March. If you have ...

Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.